Nucleic Acid Amplification Testing (NAAT) Molecular Analyzers

The Defense Health Agency Contracting Activity (DHACA), Healthcare Contracting Division – South (HCD-S), is conducting a Request for Information (RFI) to identify potential contractors capable of providing Nucleic Acid Amplification Testing (NAAT) Molecular Analyzers for Naval Hospital Pensacola, FL. The anticipated NAICS code for this acquisition is 334516, Analytical Laboratory Instrument Manufacturing. The government is exploring whether to set aside this requirement for small businesses or pursue full and open competition, based on responses received. This RFI is purely for market research purposes and not a solicitation for offers, meaning no awards will be made based on the responses. Interested parties should provide company information and relevant qualifications by March 17, 2025, with no extensions allowed. The RFI encourages small businesses to detail their qualifications and certifications relative to the NAICS code. Correspondence regarding this RFI should be directed to the specified points of contact within DHACA, ensuring compliance with established privacy regulations. Ultimately, the goal is to collect data on potential qualified offerors for NAAT Molecular Analyzers.

The Statement of Work outlines a federal request for proposal aimed at acquiring cost-per-kit (CPK) services for Rapid Molecular Analyzers to be used by the Naval Hospital Pensacola. The contractor is expected to supply comprehensive services including labor, materials, equipment, training, and maintenance for analyzers that perform rapid testing for infectious diseases such as Influenza A and B, SARS-CoV-2, Group A Strep, and RSV. Specifications include a user-friendly, compact benchtop analyzer with FDA approval and the capacity to handle an annual workload of 22,317 tests. Key functionalities include bi-directional connectivity with government systems and quality control capabilities. The vendor must provide training, installation, and prompt service response, including equipment replacement within 14 days if required. Furthermore, all reagents and supplies must align with OEM stipulations and delivery logistics. This document establishes vital guidelines for compliance with health and safety regulations while ensuring efficient operation within designated facility constraints.